Dynamic Technology Lab’s Aerie Pharmaceuticals AERI Stock Holding History

Dynamic Technology Lab’s Portfolio AERI Stock Details AERI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-60,106	Closed	-$422K	–	1663
2021 Q4	$422K	Buy	+60,106	New	+$629K	0.05%	667
2021 Q2	–	Sell	-12,739	Closed	-$228K	–	1676
2021 Q1	$228K	Buy	+12,739	New	+$220K	0.03%	902
2019 Q3	–	Sell	-16,712	Closed	-$494K	–	1384
2019 Q2	$494K	Buy	+16,712	New	+$644K	0.08%	420
2017 Q3	–	Sell	-7,957	Closed	-$418K	–	1458
2017 Q2	$418K	Buy	7,957 +2,259	+40%	+$105K	0.08%	504
2017 Q1	$259K	Buy	+5,698	New	+$254K	0.06%	670

Other funds holding AERI

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return

RHJA

Rice Hall James & Associates San Diego, California $1.8B AUM 36.16% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dynamic Technology Lab's AERI Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Aerie Pharmaceuticals (AERI) in Q1 2022, closing a stake of 60,106 shares — an estimated $422K sold.

Dynamic Technology Lab first reported a position in AERI in Q1 2017 and held it in 5 quarters. The position peaked at $494K in Q2 2019. 136 funds tracked by Wall St. Rank hold AERI as of Q1 2022.

Dynamic Technology Lab reported no remaining Aerie Pharmaceuticals position as of Q1 2022 after selling out during the quarter.
Dynamic Technology Lab sold 60,106 Aerie Pharmaceuticals shares in Q1 2022, an estimated $422K.
Dynamic Technology Lab first reported a position in Aerie Pharmaceuticals in Q1 2017 and held it in 5 quarters.
Dynamic Technology Lab's Aerie Pharmaceuticals position peaked at $494K in Q2 2019.
136 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.